[HTML][HTML] Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis
AC Paiva-Santos, M Gama, D Peixoto… - International journal of …, 2022 - Elsevier
Atopic dermatitis (AD) is a chronic disease that affects the skin, and that is characterized by
highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current …
highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current …
Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis
AC Paiva-Santos, M Gama… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Atopic dermatitis (AD) is a chronic disease that affects the skin, and that is characterized by
highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current …
highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current …
Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis.
M Gama, D Peixoto, I Sousa-Oliveira… - International Journal …, 2022 - europepmc.org
Atopic dermatitis (AD) is a chronic disease that affects the skin, and that is characterized by
highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current …
highly itchy inflammation, frequent eczematous lesions, and a fluctuating course. The current …